Shoulder Innovations Amends S-1, Signals Imminent IPO

TL;DR

**SHOULDER INNOVATIONS is gearing up for an IPO, making it a speculative buy for growth-hungry investors in the medical device space.**

AI Summary

SHOULDER INNOVATIONS, INC. filed an S-1/A on July 25, 2025, as Amendment No. 3 to its S-1 Registration Statement, indicating an upcoming public offering. The company, classified under Surgical & Medical Instruments & Apparatus (SIC 3841), is based in Grand Rapids, Michigan. While specific revenue and net income figures are not detailed in this excerpt, the filing signals a strategic move towards public capital markets to fund its operations and growth initiatives in the medical device sector. Key business changes include the formalization of its intent to sell securities to the public, as soon as practicable after the effective date of the Registration Statement. Risks associated with this offering would typically involve market acceptance of its medical devices and the competitive landscape, though specific risks are not enumerated in this snippet. The strategic outlook is focused on leveraging public funding to expand its market presence and product development in shoulder innovation.

Why It Matters

This S-1/A filing is a critical step for Shoulder Innovations, Inc., signaling its intent to go public and raise capital, which could fuel innovation in the orthopedic medical device market. For investors, it represents a new opportunity in a specialized healthcare segment, though competition from established players like Zimmer Biomet and Stryker is intense. Employees could see increased opportunities and potential stock-based compensation, while customers might benefit from accelerated product development and wider availability of advanced shoulder solutions. The broader market gains a new publicly traded entity in the medical instruments sector, potentially driving further M&A activity and technological advancements.

Risk Assessment

Risk Level: medium — The risk level is medium because while the S-1/A indicates a move towards public offering, specific financial performance, competitive challenges, and regulatory hurdles are not detailed in this excerpt. The company operates in the highly regulated and competitive medical device industry (SIC 3841), which inherently carries significant market and operational risks, even without explicit numbers cited in this snippet.

Analyst Insight

Investors should closely monitor subsequent filings for detailed financials, competitive analysis, and specific use of proceeds. Consider a small, speculative position only after a thorough review of the full S-1, focusing on market size, product differentiation, and management's experience in the orthopedic sector.

Financial Highlights

debt To Equity

X.X

revenue

$X

operating Margin

X%

total Assets

$X

total Debt

$X

net Income

$X

eps

$X

gross Margin

X%

cash Position

$X

revenue Growth

+X%

Executive Compensation

Key Numbers

• 3841 — Standard Industrial Classification Code (Identifies the company as a Surgical & Medical Instruments & Apparatus manufacturer.)
• 2025-07-25 — Filing Date (Date the S-1/A was filed with the SEC.)
• 3 — Amendment Number (This is the third amendment to the original S-1 Registration Statement.)
• 0001699350 — Central Index Key (CIK) (Unique identifier for SHOULDER INNOVATIONS, INC. with the SEC.)
• 27-0538764 — IRS Employer Identification Number (EIN) (Tax identification number for the company.)

Key Players & Entities

• SHOULDER INNOVATIONS, INC. (company) — Registrant for S-1/A filing
• Robert Ball (person) — Chief Executive Officer and Executive Chairman
• Jeffrey Points (person) — Chief Financial Officer
• Latham & Watkins LLP (company) — Legal counsel for registrant
• Cooley LLP (company) — Legal counsel for registrant
• Honigman LLP (company) — Legal counsel for registrant
• U.S. Securities and Exchange Commission (regulator) — Receiving body for S-1/A filing
• Delaware (regulator) — State of incorporation
• 333-288549 (regulator) — SEC File Number for the S-1 Registration Statement
• 616-294-1026 (dollar_amount) — Business phone number

FAQ

Industry Context

Shoulder Innovations, Inc. operates within the Surgical & Medical Instruments & Apparatus industry (SIC 3841). This sector is characterized by innovation in medical technology, stringent regulatory oversight, and a competitive landscape driven by product efficacy and market adoption. Companies in this space often focus on developing specialized devices for orthopedic procedures, aiming to improve patient outcomes and surgeon efficiency.

Regulatory Implications

As a medical device company pursuing an IPO, Shoulder Innovations, Inc. is subject to rigorous SEC regulations for public companies and ongoing compliance with FDA regulations for its products. The S-1/A filing itself is a key regulatory step, requiring comprehensive disclosure of business operations, financial health, and potential risks.

What Investors Should Do

1. [object Object]
2. [object Object]

Key Dates

• 2025-07-25: Filing of Amendment No. 3 to S-1 Registration Statement — Indicates the company is progressing towards its initial public offering and has provided updated information to the SEC.

Glossary

S-1/A

An amendment to an S-1 Registration Statement, which is filed with the SEC by companies intending to go public. It contains detailed information about the company's business, financial condition, management, and the proposed offering. (This filing signifies Shoulder Innovations, Inc.'s formal step towards becoming a publicly traded company.)

SIC Code 3841

Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus. This categorizes companies involved in the manufacturing of medical, surgical, and dental instruments. (Classifies Shoulder Innovations, Inc. within the medical device manufacturing sector, providing context for its industry and competitors.)

Registration Statement

A document required by the U.S. Securities and Exchange Commission (SEC) that provides disclosure of material information about a company offering securities to the public. (The S-1/A is an update to the initial registration statement, showing progress in the IPO process.)

Year-Over-Year Comparison

As this is Amendment No. 3 to the S-1 Registration Statement, specific year-over-year financial comparisons are not directly available from this filing excerpt. However, the filing indicates a progression in the company's journey towards becoming a public entity, suggesting ongoing operational development and strategic planning since its initial S-1 filing.

From the Filing

0001628280-25-036019.txt : 20250725 0001628280-25-036019.hdr.sgml : 20250725 20250725122937 ACCESSION NUMBER: 0001628280-25-036019 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 15 FILED AS OF DATE: 20250725 DATE AS OF CHANGE: 20250725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SHOULDER INNOVATIONS, INC. CENTRAL INDEX KEY: 0001699350 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 270538764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-288549 FILM NUMBER: 251150474 BUSINESS ADDRESS: STREET 1: 13827 PORT SHELDON STREET CITY: HOLLAND STATE: MI ZIP: 49424 BUSINESS PHONE: 616-566-0286 MAIL ADDRESS: STREET 1: 13827 PORT SHELDON STREET CITY: HOLLAND STATE: MI ZIP: 49424 S-1/A 1 shoulderinnovation-sx1a3.htm S-1/A Document As filed with the U.S. Securities and Exchange Commission on July 25, 2025. Registration No. 333-288549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Shoulder Innovations, Inc. (Exact name of registrant as specified in its charter) Delaware 3841 27-0538764 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1535 Steele Avenue SW, Suite B Grand Rapids, Michigan 49507 (616) 294-1026 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Robert Ball Chief Executive Officer and Executive Chairman Shoulder Innovations, Inc. 1535 Steele Avenue SW, Suite B Grand Rapids, Michigan 49507 (616) 294-1026 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: B. Shayne Kennedy Ross McAloon Latham & Watkins LLP 650 Town Center Drive 20 th Floor Costa Mesa, California 92626 (714) 540-1235 Jeffrey Points Chief Financial Officer Shoulder Innovations, Inc. 1535 Steele Avenue SW Suite B Grand Rapids, Michigan 49507 (616) 294-1026 Denny Won Charles S. Kim Kristin VanderPas Dave Peinsipp Cooley LLP 3 Embarcadero Center, 20th Floor San Francisco, California 94111 (415) 693-2000 Honigman LLP 650 Trade Centre Way, Suite 200 Kalamazoo, Michigan 49002 (269) 337-7700 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer &#9744